Many people believe because they are “fully vaccinated” they are protected from becoming infected with COVID19. Unfortunately, sometimes, that’s a false belief – because immunity wanes over time, and not every vaccine works.

Others believe they may have “had it”, and must therefore be protected. Unfortunately, not everyone generates neutralising spike antibodies after infection, so testing for antibodies reveals the reality, and the risk.

Booster apathy from the misbelief that if more boosters are needed, the last ones must not have worked, also overlooks that having “antibodies” and sufficient spike specific IgG antibodies is what matters. Immunity wanes, and boosters recover the fallen immunity level revealed in a COVID19 BioCard™.

Unfortunately, such assumptions result in people taking risks they would be less likely to take if they knew the reality of their immune status.

If you have previously had COVID-19, even asymptomatically, or had a vaccination, thankfully you are likely to have some established some level of immunity, at least initially.

However, not always, and the level of immunity will vary from person to person before waning away – however healthy you are.

When that occurs, live infection is more likely, and whilst for many with fair levels of immunity, that can result in mild flu-like symptoms, others the virus is passed onto – aren’t so lucky.

The long-term consequences of repeated live infection remain far from certain, so preventing the risk of infection occurring whenever possible, may prove a more rational approach in the years to come.

Only the COVID19 BioCard™ matches the full potential response to vaccines (beyond just the RBD), providing a meaningful scale to reveal your current immune level, measuring the concentration of longer-term spike specific IgG antibodies without erroneous short term signals skewing the reading.

Understanding your individual level of immunity today provides an insight into when a booster is necessary, and how well your own immune response to it was.

Borne out of independent British research, and manufactured in the UK within an MHRA regulated company, the COVID19 BioCard™ has an accuracy on a par or better than the majority of ELISA or CLIA systems, uniquely detecting all MHRA NIBSC COVID19 samples, and all UK NEQAS blind trials correctly.

The UK MHRA TPP requires 98% sensitivity or above, in official validation with its data reviewed by the UK MHRA, the COVID-19 BioCard™ attained 100% sensitivity, >99.5% Specificity.

The COVID19 BioCard™ is unique. It detects the full spike antibody response that can potentially come from vaccination or exposure, not just part of it. When doing so, it targets only the IgG Spike antibodies, without generic nucleoproteins, IgA or IgM.

Crucially, because these wane quickly, this means you can directly compare your first result to your last months later, and know the result is specific to COVID-19 – not a common cold.

When monitoring your level of immunity, the COVID19 BioCard™ uniquely establishes the level of spike antibodies you have remaining on a meaningful scale that was designed by us from our own data, not restricted by the limits of inadequate LFT technologies.

The unique BioCard™ scale reveals that many immunities classified at the maximum “Grade 3” in the WHO (World Health Organisation) system are often suboptimal, with insufficient protection to prevent vaccine breakthrough.

The BioCard™ is the essential pandemic test which establishes evidence your immune system has learnt what it needs to make -, and at what meaningful level, should you become exposed to the virus.

If exposed to the virus, immunity levels can increase without a booster, even if you don’t get sick and an LFT missed the infection. Monitoring and getting an understanding of your own immunity can help identify if, or when, you were exposed.

It can also allow you to make an informed choice to help you decide if, or when, a booster vaccine is really needed – so your own immunity can last at higher levels for longer.

The well-known Lateral Flow (LFT) and Polymerase Chain Reaction tests (PCR) will check if an individual carries the Covid-19 virus. However, unlike Covid-19 BioCard™ they do not accurately check if you have any immunity to the virus or reveal the level of antibodies in your system.

The process is simple – we will post you a specially CE marked home bleed kit to your door, optimised by us for the BioCard™. This includes everything needed with no hidden costs to take the blood sample. A pre-paid Royal Mail tracked delivery returns pack is also included. The sample can be posted to our own UK ISO accredited laboratories and processed through for testing.

Our automated digitally coded system will then keep you updated every step of the way via email.

Click here for full instructions

Click here for technical information